ABSTRACT
Men who become persistently incontinent after undergoing prostatectomy have a variety of options for regaining control, ranging from behavioral changes to surgery. To determine the best therapy, one should define the problem with a thorough urologic evaluation.
Footnotes
↵* Dr. Atiemo has indicated that he is on the speaker’s bureau of the Pfizer corporation.
↵† Dr. Vasavada has indicated that he serves as a consultant or on the speaker’s bureaus of the Novartis and Pfizer corporations and owns stock in the Neurostim Design and Innovation Medical corporation.
↵‡ Dr. Rackley has indicated that he has received grant or research support from the Allergan and Novartis corporations and the Interstitial Cystitis Association; serves as a consultant or on the speaker’s bureau of the Allergan, American Medical Systems, Astellas, Boston Scientific, Novartis, and Pfizer corporations; and owns stock in the Neurostim Design and Innovation Medical corporation.
- Copyright © 2007 The Cleveland Clinic Foundation. All Rights Reserved.